IDEXX LABORATORIES INC /DE Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD from Q1 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Idexx Laboratories Inc /De quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2019 to Q2 2025.
  • Idexx Laboratories Inc /De Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending June 30, 2025 was $21.6M, a 1.2% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2025 $21.6M -$262K -1.2% Jun 30, 2025 10-Q 2025-08-04
Q1 2025 $20.2M -$1.97M -8.86% Mar 31, 2025 10-Q 2025-05-01
Q4 2024 $20.7M -$424K -2.01% Dec 31, 2024 10-K 2025-02-21
Q3 2024 $22.4M +$648K +2.98% Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $21.9M +$311K +1.44% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $22.2M +$897K +4.21% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $21.1M +$90K +0.43% Dec 31, 2023 10-K 2024-02-22
Q3 2023 $21.8M +$3.88M +21.7% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $21.6M +$3.01M +16.2% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $21.3M +$7.62M +55.7% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $21M +$6.1M +40.9% Dec 31, 2022 10-K 2023-02-16
Q3 2022 $17.9M +$2.52M +16.4% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $18.6M +$2.28M +14% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $13.7M -$1.28M -8.56% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $14.9M +$66K +0.45% Dec 31, 2021 10-K 2022-02-16
Q3 2021 $15.4M +$640K +4.35% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $16.3M +$7K +0.04% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $15M -$572K -3.69% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $14.8M -$1.44M -8.85% Dec 31, 2020 10-K 2021-02-12
Q3 2020 $14.7M -$2.48M -14.4% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $16.3M -$1.81M -10% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $15.5M -$2.74M -15% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 $16.3M Dec 31, 2019 10-K 2020-02-14
Q3 2019 $17.2M Sep 30, 2019 10-Q 2019-10-31
Q2 2019 $18.1M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $18.3M Mar 31, 2019 10-Q 2019-05-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.